Welcome to our dedicated page for Cosmos Holdings news (Ticker: COSM), a resource for investors and traders seeking the latest updates and insights on Cosmos Holdings stock.
Cosmos Health Inc, also known as Cosmos Health, is a global healthcare group engaged in innovative R&D, pharmaceuticals & nutraceuticals manufacturing, and healthcare product distribution. The company owns proprietary brands like Sky Premium Life and Mediterranation, providing a wide range of products to healthcare providers. In recent news, the acquisition of Pelofarm's pharmacy distribution network in Greece shows Cosmos Health's strategic expansion and revenue growth.
Rhea-AI Summary
Cosmos Health Inc. (NASDAQ:COSM) filed a patent application with the European Patent Office for its CCX0722 obesity and weight management product, showcasing significant advancements and promising results in its R&D pipeline.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.65%
Tags
-
Rhea-AI Summary
Cosmos Health Inc. (COSM) reported Q3 2023 revenues of $12.8M, a 7% increase YoY, with a solid balance sheet, but decreased gross margins and negative Adjusted EBITDA. The company also announced a strategic collaboration, a capital raise, and guidance to surpass $180M in gross annual revenue and $20M in EBITDA by 2026.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.36%
Tags
-
Rhea-AI Summary
Cosmos Health Inc. announces acquisition of Cloudscreen®, an AI-powered platform for drug repurposing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.71%
Tags
Rhea-AI Summary
Cosmos Health Inc. announces major strategic inflection point and strong financial position
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
-
Rhea-AI Summary
Cosmos Health Inc. plans to spin off its R&D division into a standalone biotech company, aiming to unlock shareholder value. The company has been investing in innovative R&D projects, including the CCX0722 product for obesity and weight management. Clinical trials for the product are scheduled to begin in Q4 2023. The spin-off decision is based on analysis of comparable biotech companies. Cosmos Health is also executing a buyback program to return capital to shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.16%
Tags
-
Rhea-AI Summary
Cosmos Health expands C-Sept brand with C-Scrub Wash 4% CHG Biocide, expecting significant growth in revenues and profitability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.83%
Tags
Rhea-AI Summary
Cosmos Health relaunches organic infant care and nutrition brand bio-bebe® after acquiring Cana Laboratories. The relaunch aims to penetrate markets across Europe and beyond. The baby food market is projected to grow from $102.90 billion in 2023 to $161.16 billion by 2030. bio-bebe® products expected to be launched in Q1 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.82%
Tags
-
Rhea-AI Summary
Cosmos Health enters strategic collaboration with C.A.PAPAELLINAS Group for distribution of nutraceuticals in Cyprus
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.67%
Tags
-
Rhea-AI Summary
Cosmos Health Inc. announces stock buyback program to enhance shareholder value
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
Rhea-AI Summary
Cosmos Health reaches major inflection point with revenue ramp-up and introduces 2026 guidance. Targeting over $180M in annual revenue and EBITDA in excess of $20M. Completed three acquisitions and made progress in R&D. Nutraceutical brands experiencing market success. Maintains robust balance sheet. Exploring initiatives to enhance shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
34.34%
Tags
FAQ
What is the current stock price of Cosmos Holdings (COSM)?
The current stock price of Cosmos Holdings (COSM) is $0.5829 as of December 20, 2024.
What is the market cap of Cosmos Holdings (COSM)?
The market cap of Cosmos Holdings (COSM) is approximately 14.8M.
What is Cosmos Health Inc known for?
Cosmos Health Inc is a global healthcare group engaged in R&D, pharmaceuticals & nutraceuticals manufacturing, and healthcare product distribution.
What proprietary brands does Cosmos Health Inc own?
Cosmos Health Inc owns proprietary brands like Sky Premium Life and Mediterranation.
What recent development has Cosmos Health Inc made?
Recent news includes the acquisition of Pelofarm's pharmacy distribution network in Greece, showcasing strategic expansion and revenue growth.
Where does Cosmos Health Inc operate?
Cosmos Health Inc is currently expanding throughout Europe, Asia, and North America, with offices and distribution centers in Thessaloniki, Athens, and Harlow.
How is Cosmos Health Inc leveraging technology in its operations?
Cosmos Health Inc utilizes advanced technological systems like A-Frame and ROWA in its facilities for automated procurement, inventory management, and order execution.
Cosmos Holdings Inc.
Nasdaq:COSM
COSM Rankings
COSM Stock Data
14.84M
19.72M
15.51%
10.28%
1.56%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
United States of America
THESSALONIKI